NCT07126496 A Virtual Community Health Educator for Increasing Clinical Trial Referrals Among Cancer Patients and Their Caregivers
| NCT ID | NCT07126496 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2025-05-20 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,000 participants in total. It began in 2025-05-20 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial studies how well a virtual community health educator (vCHE) works in increasing clinical trial referrals for patients with cancer and their caregivers. Low enrollment of underrepresented and underserved populations in cancer clinical trials has led to disparities in intervention development and implementation. One approach to recruiting diverse populations to cancer clinical trials is community health educators. However, community health educator interventions are costly and difficult to implement. vCHEs are photo-realistic virtual agents that provide personalized guidance and support to users. They are designed to mimic real-life community health workers, offering culturally and linguistically tailored information to users. They can communicate in English or Spanish and are available in diverse genders and racial/ethnic backgrounds. vCHEs may be able to increase the enrollment of diverse participants into cancer clinical trials.
Eligibility Criteria
Inclusion Criteria: * Individuals Diagnosed with Cancer * 18 years or older * Must have received a cancer diagnosis at any point in your life * Able to understand English or Spanish * Care Partners * Must be a care partner (also known as caregiver, carer, supporter, helper, aide, assistant, companion, attendant, advocate, or family caregiver) of an adult who has received a cancer diagnosis * Must be actively involved in the decision-making process OR care of a person diagnosed with cancer * Must be 18 years or older Exclusion Criteria: * Self-reported: people who are currently or have been in a cancer clinical trial within the last 3 years
Contact & Investigator
Janice L. Krieger, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07126496 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hematopoietic and Lymphatic System Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07126496 currently recruiting?
Yes, NCT07126496 is actively recruiting participants. Contact the research team at ETCH@mayo.edu for enrollment information.
Where is the NCT07126496 trial being conducted?
This trial is being conducted at Jacksonville, United States.
Who is sponsoring the NCT07126496 clinical trial?
NCT07126496 is sponsored by Mayo Clinic. The principal investigator is Janice L. Krieger, PhD at Mayo Clinic. The trial plans to enroll 2,000 participants.